Live Breaking News & Updates on Translational Lung Cancer Research

Stay updated with breaking news from Translational lung cancer research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lantern Pharma Receives Regulatory Approval to Expand Harmonic Clinical Trial for Non-Small Cell Lung Cancer in Never-Smokers into Japan and Taiwan

22.04.2024 - Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, . Seite 1 ....

Translational Lung Cancer Research , Lantern Pharma Inc , Lantern Pharma , East Asia , Translational Lung Cancer , Lantern Pharma Chart , Antern Pharma Kurs , Antern Pharma Aktie ,

Building a Path to Cure for Patients With NSCLC Who Have Never Smoked

How patients acquire NSCLC plays a role in health outcomes, with never-smoker patients having genetically different disease than the same disease in smokers. ....

United States , Centers For Disease , Translational Lung Cancer Research , Lantern Pharma , Disease Control , Lung Cancer , Accessed November ,